Novartis Discloses Tumor Reports After Zolgensma Treatment

A November 5 Novartis statement disseminated by SMA patient organizations reports nine tumors worldwide in children previously treated with Zolgensma among more than 6,000 treated patients. Two cases have shown vector DNA integration in…






